A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa.
In a study of 5,000 young women and girls, there were no infections in those who got the shots.Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday.
Gilead paid for the study and some of the researchers are company employees. Because of the surprisingly encouraging results, the study was stopped early and all participants were offered the shots, also known as lenacapavir., like condoms or daily pills, consistent use has been a problem in Africa. In the new study, only about 30% of participants given Gilead's Truvada or Descovy prevention pills actually took them — and that figure dropped over time.
She said her organization urged Gilead to share Sunlenca's patent with a U.N.-backed program that negotiates broad contracts allowing generic drugmakers to make cheap versions of drugs for poorer countries worldwide. As an HIV treatment, the drug costs more than $40,000 a year in the U.S., although what individuals pay varies.
Another HIV prevention shot, Apretude, which is given every two months, is approved in some countries, including in Africa. It sells for about $180 per patient per year, which is still too pricey for most developing countries.
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa.
Read more »
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa.
Read more »
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa.
Read more »
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa. The shot is already used in the U.S. and elsewhere as a treatment for the virus that causes AIDS, and drugmaker Gilead is testing it for prevention.
Read more »
Experts say injection that offers 100% protection against HIV is 'stunning'A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa
Read more »
Experts laud injection that reportedly offers 100% protection against HIV/AIDSA study shows that a shot was 100% effective in preventing new HIV infections in women in Africa. The shot is used in the U.S. as a treatment for the virus that causes AIDS.
Read more »